These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26638776)

  • 1. Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution.
    Kasar S; Kim J; Improgo R; Tiao G; Polak P; Haradhvala N; Lawrence MS; Kiezun A; Fernandes SM; Bahl S; Sougnez C; Gabriel S; Lander ES; Kim HT; Getz G; Brown JR
    Nat Commun; 2015 Dec; 6():8866. PubMed ID: 26638776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV
    Burns A; Alsolami R; Becq J; Stamatopoulos B; Timbs A; Bruce D; Robbe P; Vavoulis D; Clifford R; Cabes M; Dreau H; Taylor J; Knight SJL; Mansson R; Bentley D; Beekman R; Martín-Subero JI; Campo E; Houlston RS; Ridout KE; Schuh A
    Leukemia; 2018 Feb; 32(2):332-342. PubMed ID: 28584254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia.
    Heintel D; Kroemer E; Kienle D; Schwarzinger I; Gleiss A; Schwarzmeier J; Marculescu R; Le T; Mannhalter C; Gaiger A; Stilgenbauer S; Döhner H; Fonatsch C; Jäger U;
    Leukemia; 2004 Apr; 18(4):756-62. PubMed ID: 14961036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.
    Marantidou F; Dagklis A; Stalika E; Korkolopoulou P; Saetta A; Anagnostopoulos A; Laoutaris N; Stamatopoulos K; Belessi C; Scouras Z; Patsouris E
    Blood Cells Mol Dis; 2010 Apr; 44(4):262-7. PubMed ID: 20117026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of Mutational Signature Analysis with 3D Chromatin Data Unveils Differential AID-Related Mutagenesis in Indolent Lymphomas.
    Sepulveda-Yanez JH; Alvarez-Saravia D; Fernandez-Goycoolea J; Aldridge J; van Bergen CAM; Posthuma W; Uribe-Paredes R; Veelken H; Navarrete MA
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational landscape and underlying mutational processes in chronic lymphocytic leukemia.
    Kasar S; Brown JR
    Mol Cell Oncol; 2016 Jul; 3(4):e1157667. PubMed ID: 27652313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation-induced cytidine deaminase mRNA levels in chronic lymphocytic leukemia.
    Hancer VS; Kose M; Diz-Kucukkaya R; Yavuz AS; Aktan M
    Leuk Lymphoma; 2011 Jan; 52(1):79-84. PubMed ID: 21133730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasms.
    Morande PE; Yan XJ; Sepulveda J; Seija N; Marquez ME; Sotelo N; Abreu C; Crispo M; Fernández-Graña G; Rego N; Bois T; Methot SP; Palacios F; Remedi V; Rai KR; Buschiazzo A; Di Noia JM; Navarrete MA; Chiorazzi N; Oppezzo P
    Blood; 2021 Jul; 138(3):246-258. PubMed ID: 34292322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease.
    Palacios F; Moreno P; Morande P; Abreu C; Correa A; Porro V; Landoni AI; Gabus R; Giordano M; Dighiero G; Pritsch O; Oppezzo P
    Blood; 2010 Jun; 115(22):4488-96. PubMed ID: 20233972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone.
    Albesiano E; Messmer BT; Damle RN; Allen SL; Rai KR; Chiorazzi N
    Blood; 2003 Nov; 102(9):3333-9. PubMed ID: 12855567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of somatic hypermutations in the TP53 gene in B-cell chronic lymphocytic leukemia.
    Malcikova J; Smardova J; Pekova S; Cejkova S; Kotaskova J; Tichy B; Francova H; Doubek M; Brychtova Y; Janek D; Pospisilova S; Mayer J; Dvorakova D; Trbusek M
    Mol Immunol; 2008 Mar; 45(5):1525-9. PubMed ID: 17920683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery.
    Degan M; Bomben R; Bo MD; Zucchetto A; Nanni P; Rupolo M; Steffan A; Attadia V; Ballerini PF; Damiani D; Pucillo C; Poeta GD; Colombatti A; Gattei V
    Br J Haematol; 2004 Jul; 126(1):29-42. PubMed ID: 15198729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature.
    Pettersen HS; Galashevskaya A; Doseth B; Sousa MM; Sarno A; Visnes T; Aas PA; Liabakk NB; Slupphaug G; Sætrom P; Kavli B; Krokan HE
    DNA Repair (Amst); 2015 Jan; 25():60-71. PubMed ID: 25486549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuating homologous recombination stimulates an AID-induced antileukemic effect.
    Lamont KR; Hasham MG; Donghia NM; Branca J; Chavaree M; Chase B; Breggia A; Hedlund J; Emery I; Cavallo F; Jasin M; Rüter J; Mills KD
    J Exp Med; 2013 May; 210(5):1021-33. PubMed ID: 23589568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dark side of activation-induced cytidine deaminase: relationship with leukemia and beyond.
    Kinoshita K; Nonaka T
    Int J Hematol; 2006 Apr; 83(3):201-7. PubMed ID: 16720548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia.
    Zaprazna K; Reblova K; Svobodova V; Radova L; Bystry V; Baloun J; Durechova K; Tom N; Loja T; Buresova M; Stranska K; Oltova A; Doubek M; Atchison ML; Trbusek M; Malcikova J; Pospisilova S
    Ann Hematol; 2019 Feb; 98(2):423-435. PubMed ID: 30368590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome.
    Caratão N; Cortesão CS; Reis PH; Freitas RF; Jacob CM; Pastorino AC; Carneiro-Sampaio M; Barreto VM
    Clin Immunol; 2013 Aug; 148(2):279-86. PubMed ID: 23803409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal evolution in chronic lymphocytic leukemia: analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance.
    López C; Delgado J; Costa D; Villamor N; Navarro A; Cazorla M; Gómez C; Arias A; Muñoz C; Cabezas S; Baumann T; Rozman M; Aymerich M; Colomer D; Pereira A; Cobo F; López-Guillermo A; Campo E; Carrió A
    Genes Chromosomes Cancer; 2013 Oct; 52(10):920-7. PubMed ID: 23893575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia.
    Rebhandl S; Huemer M; Zaborsky N; Gassner FJ; Catakovic K; Felder TK; Greil R; Geisberger R
    Eur J Immunol; 2014 Jul; 44(7):2175-87. PubMed ID: 24668151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.